Corinnova
VerifiedCorinnova is commercializing a breakthrough technological platform for the treatment of congestive heart failure.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$24—37m (Dealroom.co estimates Oct 2017.)
Houston Texas (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | $990k | Grant | |
| Total Funding | 000k | ||
Related Content
Recent News about Corinnova
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.